Murine Respiratory Tract Infection with Classical Klebsiella pneumoniae Induces Bronchus-Associated Lymphoid Tissue

Rachel K Wasbotten1, Aubree A Dahler1, Joseph J Mackel1

  • 1Department of Pediatrics, Division of Pediatric Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.

Infection and Immunity
|March 21, 2022
PubMed

Insights

Klebsiella pneumoniae infection in mice forms inducible bronchus-associated lymphoid tissue (iBALT) in the lungs. These immune structures, crucial for pulmonary immunity, contain B and T cells and develop following bacterial challenge.

Area of Science:

  • Immunology
  • Microbiology
  • Pathology

Background:

  • Klebsiella pneumoniae is a significant Gram-negative opportunistic pathogen causing various infections.
  • Previous studies showed leukocyte aggregates in murine lungs post-K. pneumoniae infection.

Purpose of the Study:

  • To characterize the composition and development of immune cell aggregates in murine lungs after K. pneumoniae infection.
  • To determine if these structures represent inducible bronchus-associated lymphoid tissue (iBALT).

Main Methods:

  • Histopathological analysis of murine lung tissues.
  • Immunohistochemistry to identify immune cell populations (B cells, T cells) and markers (germinal center, CXCL12).
  • Studies using B cell and T cell deficient mice.
  • Assessment of iBALT longevity and response to re-stimulation.

Main Results:

  • Immune cell clusters resembling iBALT formed around pulmonary vasculature and airways by 14 days post-infection.
  • These structures contained central B cell aggregates and dispersed T cells, expressing germinal center markers and CXCL12 by day 28.
  • iBALT formation was dependent on the presence of both B and T cells.
  • K. pneumoniae-induced iBALT decreased by 90 days but persisted with repeated infections.
  • Development of iBALT was observed with various K. pneumoniae clinical isolates.

Conclusions:

  • Murine lungs infected with K. pneumoniae develop iBALT structures.
  • These iBALT structures possess nonclassical B cell follicles and may play a role in pulmonary immunity against K. pneumoniae.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...